POTED - POTE ankyrin domain family member D Gene

Also Known as POTE; A26B3; POTE21; ANKRD21; CT104.1; POTE-21

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 317754

About POTED

Cytogenetic location: 21q11.2 Genomic coordinates (GRCh38): 21:13,609,777-13,645,823 (from NCBI)

This gene has 2 transcripts (splice variants), 13 orthologues and 16 paralogues. Restricted expression toward testis (RPKM 4.0).

Summary

Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

POTED Products (1)

mRNA Protein Name
NM_174981.6 NP_778146.2 POTE ankyrin domain family member D

POTED Protein Structure

Ank_2

Ank_2: Ankyrin repeats (3 copies) (165 - 234)

Ank

Ank: Ankyrin repeat (238 - 270)

Ank_2

Ank_2: Ankyrin repeats (3 copies) (282 - 361)

CCDC144C

CCDC144C: CCDC144C protein coiled-coil region (526 - 582)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 500
  • 584 a.a.
Protein Preferred Names Protein Names

POTE ankyrin domain family member D

  • ANKRD26-like family B member 3

Related Diseases

Diseases Alias
Luminal Breast Carcinoma B

  • Luminal B Breast Carcinoma
Prostate Cancer

  • Prostate Carcinoma

  • Prostate Cancer, Familial

  • Prostate Neoplasm

  • Prostate Cancer, Somatic

  • Prostate Cancer, Susceptibility To

  • Prostatic Cancer

  • Prostatic Neoplasms

  • Hereditary Prostate Cancer

  • Prostatic Neoplasm

  • Cancer Of Prostate

  • Carcinoma Of Prostate

  • Familial Prostate Cancer

  • Familial Prostate Carcinoma

  • Malignant Tumor Of Prostate

  • Malignant Neoplasm Of Prostate

  • Prostate Cancer, Familial, Susceptibility To

  • Malignant Tumor Of The Prostate

  • Ngp - New Growth Of Prostate

  • Tumor Of The Prostate

  • Prostate Cancer, Hereditary

  • Cancer Of The Prostate

  • Malignant Neoplasm Of The Prostate

  • Prostatic Carcinoma

  • PC

  • Prca

  • Cancer, Prostate

  • Malignant Prostatic Tumour

  • Malignant Tumour Of Prostate

  • Primary Prostate Cancer

  • Primary Malignant Neoplasm Of Prostate

  • Prostate Gland Cancer
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-P3204 POT-4 Inhibitor 98.88% Phase 2

Pre-clinical Phase

Bioactive Molecules (6)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-42045 Pyrimidine-5-boronic acid pinacol ester 98.0% Unkown
HY-141456 Tetramethylfluthrin / Unkown
HY-P3204A POT-4 TFA Inhibitor / Unkown
HY-RS10885 POT1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10889 POTED Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-N10653 Altemicidin / Unkown

Orthologs Information

Species Symbol Source ID
Rattus norvegicus POTED RGD RGD:9472036